[1] |
Yamada H, Takamori K, Yaguchi H, et al. A study of the efficacy of plasmapheresis for the treatment of drug induced toxic epidermal necrolysis[J]. Ther Apher, 1998,2(2):153⁃156.
|
[2] |
Lissia M, Figus A, Rubino C. Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report[J]. Br J Plast Surg, 2005,58(4):504⁃510. doi: 10.1016/j.bjps.2004.12.007.
|
[3] |
Sengul SN, Ayer M, Gursu M, et al. Patients treated with therapeutic plasma exchange: a single center experience[J]. Transfus Apher Sci, 2014,51(3):83⁃89. doi: 10.1016/j.transci.2014. 10.006.
|
[4] |
Aihara M, Kano Y, Fujita H, et al. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens⁃Johnson syndrome and toxic epidermal necrolysis[J]. J Dermatol, 2015,42(8):768⁃777. doi: 10.1111/1346⁃8138.12925.
|
[5] |
Bastuji⁃Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity⁃of⁃illness score for toxic epidermal necrolysis[J]. J Invest Dermatol, 2000,115(2):149⁃153. doi: 10.1046/j.1523⁃1747. 2000.00061.x.
|
[6] |
王昱璐, 左亚刚, 刘洁, 等. SCORTEN评分对中毒性表皮坏死松解症和Stevens⁃Johnson综合征评估分析[J]. 中华皮肤科杂志, 2016,49(9):651⁃653. doi: 10.3760/cma.j.issn.0412⁃4030.2016. 09.011.
|
[7] |
Boulard C, Duvert LS, Picard⁃Dahan C, et al. Calculation of cut⁃off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus[J]. Br J Dermatol, 2016,175(1):142⁃149. doi: 10.1111/bjd.14405.
|
[8] |
谭艳, 高志刚. 数字化测量烧伤面积的研究与应用[J]. 局解手术学杂志, 2017,26(3):224⁃228. doi: 10.11659/jjssx.10E016017.
|
[9] |
Creamer D, Walsh SA, Dziewulski P, et al. UK guidelines for the management of Stevens⁃Johnson syndrome/toxic epidermal necrolysis in adults 2016[J]. J Plast Reconstr Aesthet Surg, 2016,69(6):e119⁃e153. doi: 10.1016/j.bjps.2016.01.034.
|
[10] |
Lerch M, Mainetti C, Terziroli BB, et al. Current perspectives on Stevens⁃Johnson syndrome and toxic epidermal necrolysis[J]. Clin Rev Allergy Immunol, 2018,54(1):147⁃176. doi: 10.1007/s12016⁃017⁃8654⁃z.
|
[11] |
章泳, 王向东, 沈宏. 糖皮质激素联合免疫球蛋白治疗中毒性表皮坏死松解症九例[J]. 中华皮肤科杂志, 2007,40(2):85. doi: 10.3760/j.issn:0412⁃4030.2007.02.022.
|
[12] |
Mohanty S, Das A, Ghosh A, et al. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens⁃Johnson syndrome/toxic epidermal necrolysis: a record⁃based study[J]. Indian J Dermatol Venereol Leprol, 2017,83(3):312⁃316. doi: 10.4103/ijdvl.IJDVL_201_16.
|
[13] |
Kreft B, Wohlrab J, Bramsiepe I, et al. Etoricoxib⁃induced toxic epidermal necrolysis: successful treatment with infliximab[J]. J Dermatol, 2010,37(10):904⁃906. doi: 10.1111/j.1346⁃8138.2010. 00893.x.
|
[14] |
Han F, Zhang J, Guo Q, et al. Successful treatment of toxic epidermal necrolysis using plasmapheresis: a prospective obser⁃vational study[J]. J Crit Care, 2017,42:65⁃68. doi: 10.1016/j.jcrc. 2017.07.002.
|